Refine by
Drug Discovery Software
18 software items found
by:Acellera based inStanmore, UNITED KINGDOM
PlayMolecule is our platform for computable drug discovery where algorithms, data and computers integrate to discover new ...
by:Strateos Inc. based inMenlo Park, CALIFORNIA (USA)
The Strateos Platform automates chemistry, biology, and tissue analysis into closed loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, we enable our pharmaceutical partners to more rapidly and efficiently ...
Manufactured by:Intelligence based inEschborn, GERMANY
Ontosight Explore enables the exploration, detection and building of various direct and in-direct connections between drug, target, pathway and disease. We leverage a biological network model using enhanced natural language processing, statistical scoring approach and entity normalization. Our self learning, life science ontology, has more than 20 million concepts and terms and brings together ...
Manufactured by:Intelligence based inEschborn, GERMANY
Innoplexus recognizes the unique requirements of the life sciences industry and offers custom solutions on top of our products to enable pharmaceutical and biotech companies as well as CROs to have timely and easy access to useful insights. Our proprietary AI technology combined with a self-learning life sciences ontology that understands the context of the search query and our capability to ...
by:Optibrium Ltd. based inCambridge, UNITED KINGDOM
Cerella™ uses a unique deep learning approach to overcome limitations in drug discovery data, reducing costs and accelerating drug discovery cycles. Cerella highlights high-quality compounds with confidence, finding hidden opportunities caused by missing, uncertain or inaccurate data and prioritises the most valuable ...
Manufactured by:Intelligence based inEschborn, GERMANY
Identify the biomarkers best suited for your needs: Diagnose rare or ambiguous diseases, Group patients by endotype response for prognosis, Assess disease etiology to determine responsive patient group ...
by:InterX based inBerkeley, CALIFORNIA (USA)
InterX Development Division focuses on bridging the risk gap in Drug Discovery from drug targets to novel candidates. The Development Division applies InterX’s proprietary computer-aided drug design platform, while developing collaborations with Research Centers, Pharma companies, Start-ups, Academia and Accelerators. Such ...
by:Genedata AG based inBasel, SWITZERLAND
By integrating and condensing complex experimental data, it powers project decisions and lays the foundation for more predictive, AI-driven, drug discovery and ...
Manufactured by:Syncro Medical based inLanghorne, PENNSYLVANIA (USA)
The growth of this market is driven largely by increasing spending on pharmaceutical R&D for a growing number of research studies related to drug discovery and development. The increasing demand for diagnostic instruments is also associated with the rising prevalence of target diseases and testing procedures related to these ...
Manufactured by:Intelligence based inEschborn, GERMANY
Ontosight® Discover – a one stop solution for all relevant information within the pharmaceutical industry. The AI and blockchain powered discovery engine connects trillions of data points to accelerate your drug discovery and research process. You get real-time data insights on a fingertip for empowered, inspired & faster decisions. ...
by:Cypre, Inc. based inSan Francisco, CALIFORNIA (USA)
Cypre’s 3D Tumor Models combine the tumor, stromal and immune compartments in a high throughput format to screen targeted drugs and immunotherapy. In 2021, we partnered with Charles River to offer our 3D Tumor Models for drug discovery and preclinical screening services. Cypre Panels rapidly screen small molecules, biologics and cell ...
by:Simulations Plus based inLancaster, CALIFORNIA (USA)
With the ability to predict over 175 properties, it integrates seamlessly with computational chemistry and medicinal chemistry applications, offering precise predictions on solubility, logP, pKa, and sites of CYP metabolism. Enhanced through high-throughput GastroPlus® simulations, it supports the decision-making process in drug discovery and risk assessment. The ...
by:Cyrus Biotechnology Inc. based inSeattle, WASHINGTON (USA)
While much traditional protein modeling software takes a pure first-principles approach using deep expert knowledge of physics and chemistry, and modern AI tools often take a model-free approach based entirely on data, the Rosetta software package takes a combined approach based on physics and on statistical patterns. This combination, along with a relentless focus on the prediction of ...
by:Cresset Group based inCambridgeshire, UNITED KINGDOM
A single platform for ligand-based and structure-based drug design that enables research chemists to discover novel small molecules more efficiently and ...
by:Lifebit based inHackney, UNITED KINGDOM
The velocity and volume of real world data (RWD) means it is impossible for humans alone to gain ultimate value from this type of information. Lifebit REAL uses Artificial Intelligence to make sense of RWD. Using REAL, you can unlock meaningful insights in real-time, so you can stay at the forefront of science innovation and ...
by:Qlucore AB based inLund, SWEDEN
The combination of powerful statistics and instant visualization drives exciting results. Flexibility and expansion are cornerstones. Analyze data using an easy to use statistical model. Integrate and extend the analysis with Python based Templates for scripting. Add statistical methods through the Open API to R. Filter on genomic entities such as read coverage and variants with the NGS module. ...
by:Genuity Science based inBoston, MASSACHUSETTS (USA)
We are developing novel causal artificial intelligence and machine learning (AI/ML) and unconventional computing strategies to better understand human biology – and then apply these to deliver better medicine and improve health for people around the ...
by:Eidogen-Sertanty, Inc. based inOceanside, CALIFORNIA (USA)
The Oncology Knowledgebase (OKB) is Eidogen-Sertanty's database of structure-activity data across numerous targets of oncological interest. Nicely complementing the Kinase Knowledgebase (KKB), the OKB will cover a broad spectrum of targets relevant to Colon cancer, Esophageal cancer, Glioma, Head and Neck cancer, Kidney cancer, Leukemia, Liver cancer, Lung cancer, Lymphoma, Melanoma, Ovarian ...